يعرض 1,941 - 1,960 نتائج من 13,350 نتيجة بحث عن '(( significantly increased decrease ) OR ( significantly ((alter decrease) OR (teer decrease)) ))', وقت الاستعلام: 0.46s تنقيح النتائج
  1. 1941
  2. 1942
  3. 1943
  4. 1944
  5. 1945
  6. 1946
  7. 1947
  8. 1948
  9. 1949
  10. 1950
  11. 1951

    Alteration of Ubiquitination in the Brain of ENOPH1 Knockout Mice after Early Ischemic Stroke حسب Yike Wu (20982007)

    منشور في 2025
    "…Our results showed that 4000 ubiquitination-modified sites in 1613 proteins were quantified, with 772 ubiquitinated sites in 464 proteins significantly decreasing or increasing after ENOPH1 knockout (fold change >1.5 or <1/1.5, <i>p</i> < 0.05). …"
  12. 1952

    Alteration of Ubiquitination in the Brain of ENOPH1 Knockout Mice after Early Ischemic Stroke حسب Yike Wu (20982007)

    منشور في 2025
    "…Our results showed that 4000 ubiquitination-modified sites in 1613 proteins were quantified, with 772 ubiquitinated sites in 464 proteins significantly decreasing or increasing after ENOPH1 knockout (fold change >1.5 or <1/1.5, <i>p</i> < 0.05). …"
  13. 1953
  14. 1954

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  15. 1955

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  16. 1956

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  17. 1957

    Bar charts showing the numbers of significantly differentially expressed genes for the different contrasts. حسب Gillian P. McHugo (8965919)

    منشور في 2025
    "…</sub> ≤ 0.05) with increased and decreased expression, respectively. The position on the horizontal indicates the number of days post-infection (dpi) and the colour of the bars represents the tissue. …"
  18. 1958

    Image 4_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg حسب Gizem Yılmaz (20641691)

    منشور في 2025
    "…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…"
  19. 1959

    Image 1_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg حسب Gizem Yılmaz (20641691)

    منشور في 2025
    "…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…"
  20. 1960

    Image 3_Pediatric kidney transplant recipients are at an increased risk for dysbiosis.jpeg حسب Gizem Yılmaz (20641691)

    منشور في 2025
    "…In addition, KTx recipients with a history of frequent urinary tract infections, diarrhea and reduced GFR showed significant increases in bacterial abundance (p < 0.05 for all).…"